Manchester, UK – 22 May 2013 - Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m.
A*STAR's Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devices. Under this collaboration, QMDx's wholly owned Singapore-based subsidiary QMDx Asia and GIS will develop Asia-specific point-of-care genetic tests for use with Q-POC™, QMDx's handheld point-of-care device.
250 guests gathered at London’s Grand Connaught Rooms to witness the inaugural UK Life Science Skills Awards, organised by Cogent, the strategic skills body for the science industries. The event, which took place on Thursday 16th May, saw 30 finalists and 11 winners, take to the stage to receive Awards across ten categories. Plus an extra, special Award for Excellence in Skills.